ArticleThe Journal of allergy and clinical immunology2015
Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy.
Article in The Journal of allergy and clinical immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 1 synthesis or guideline pooled it, 61 citations in OpenAlex.
- Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients.International journal of clinical oncology · 2021Pooled it
- Novel RP-HPLC-DAD approach for simultaneous determination of chlorphenoxamine hydrochloride and caffeine with their related substances.BMC chemistry · 2024Article
- Drug hypersensitivity reactions: review of the state of the science for prediction and diagnosis.Toxicological sciences : an official journal of the Society of Toxicology · 2024Review
- Approach for delabeling beta-lactam allergy in children.Frontiers in allergy · 2023Review
- Hypersensitivity reactions to small molecule drugs.Frontiers in immunology · 2022Review
- Review on Databases and Bioinformatic Approaches on Pharmacogenomics of Adverse Drug Reactions.Pharmacogenomics and personalized medicine · 2021Review
- Skin Resident Memory T Cells May Play Critical Role in Delayed-Type Drug Hypersensitivity Reactions.Frontiers in immunology · 2021Review
- Drug and Chemical Allergy: A Role for a Specific Naive T-Cell Repertoire?Frontiers in immunology · 2021Review
- Are you sure that it is a drug allergy?Clinical and experimental pediatrics · 2020Article
- Adverse drug reaction causality assessment tools for drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: room for improvement.European journal of clinical pharmacology · 2019Article
- Covalent Heterobivalent Inhibitor Design for Inhibition of IgE-Dependent Penicillin Allergy in a Murine Model.Journal of immunology (Baltimore, Md. : 1950) · 2019Article
- Controversies in Drug Allergy: Drug Allergy Pathways.The journal of allergy and clinical immunology. In practice · 2019Review
- Diagnosing and managing drug allergy.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018Review
- Reply to: Medication contaminants as a potential cause of anaphylaxis to vincristine: What about drug specific antigens?Pediatric blood & cancer · 2018Article
- Important questions in drug allergy and hypersensitivity: consensus papers from the 2018 AAAAI/WAO international drug allergy symposium.The World Allergy Organization journal · 2018Article
- Anaphylaxis in the 21st century: phenotypes, endotypes, and biomarkers.Journal of asthma and allergy · 2018Review
- Stevens-Johnson syndrome/toxic epidermal necrolysis and erythema multiforme drug-related hospitalisations in a national administrative database.Clinical and translational allergy · 2018Article
- Pro and Contra: Provocation Tests in Drug Hypersensitivity.International journal of molecular sciences · 2017Review
- Allergens in red ginseng extract induce the release of mediators associated with anaphylactoid reactions.Journal of translational medicine · 2017Article
- Approach to the diagnosis of drug hypersensitivity reactions: similarities and differences between Europe and North America.Clinical and translational allergy · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors at 16 institutions in 5 countries.
Funding
Abstract
Allergic reactions to drugs are a serious public health concern. In 2013, the Division of Allergy, Immunology, and Transplantation of the National Institute of Allergy and Infectious Diseases sponsored a workshop on drug allergy. International experts in the field of drug allergy with backgrounds in allergy, immunology, infectious diseases, dermatology, clinical pharmacology, and pharmacogenomics discussed the current state of drug allergy research. These experts were joined by representatives from several National Institutes of Health institutes and the US Food and Drug Administration. The participants identified important advances that make new research directions feasible and made suggestions for research priorities and for development of infrastructure to advance our knowledge of the mechanisms, diagnosis, management, and prevention of drug allergy. The workshop summary and recommendations are presented herein.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.